Thus, the Foxp3 + Treg population exhibited a trend toward a significant reduction in tumour density in Bach2-deficient animals reveals therapeutic targets for reversing cancer immunosuppression and is unquestionably a critical part of the molecular pathway involved in tumour immunosuppression. This evidence concerns the gene FOXP3 and neoplasm.